🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
The Phase I trial is evaluating safety, tolerability, pharmacokinetics and ...
Status
Recruiting
Location
Herlev and Gentofte Hospital, Center for Cancer Research
Start Date
2021-04-12
Trial ID
NCT04855435
Treatments Being Tested
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
This study is a Phase I/II, multicenter, first-in-human, open-label dose-es...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HealthONE
Start Date
2020-07-17
Trial ID
NCT04561362
Treatments Being Tested
The purpose of this study is to learn how to use blood tests to better pred...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-02-01
Trial ID
NCT04791215
Treatments Being Tested
This is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2024-12-11
Trial ID
NCT06724016
Treatments Being Tested
The goal of this clinical trial is to compare the safety and efficacy (how ...
Status
Active Not Recruiting
Location
St. Joseph Heritage Healthcare
Start Date
2021-10-27
Trial ID
NCT05117242
Treatments Being Tested
TAC01-HER2 is a novel cell therapy that consists of genetically engineered ...
Status
Terminated
Location
Lurie Cancer Center - Northwestern University
Start Date
2021-04-19
Trial ID
NCT04727151
Treatments Being Tested